Upon Mr. Cetaine's arrival in the emergency department, which of the following is a 'first-line' medication he will likely receive?

Upon Mr. Cetaine's arrival in the emergency department, which of the following is a 'first-line' medication he will likely receive?

• A. Nitroglycerine (Nitrolingual)
• B. Propranolol (Inderal)
• C. Tissue plasminogen activator (t-PA)
• D. Captopril (Capoten)

Answer: (A)

In acute coronary syndrome, the priority is to relieve chest pain and decrease the heart’s oxygen demand as quickly as possible. Nitroglycerin fits this role because it is a fast-acting vasodilator that lowers preload and, to some extent, afterload. By dilating veins, it reduces the amount of blood returning to the heart, which lessens wall stress and myocardial oxygen consumption, often quickly easing angina symptoms when given sublingually. This makes it a standard first-line intervention in the ED for suspected ACS, often part of the initial MONA approach (Nitrates among the first steps). Propranolol is a beta-blocker that can be useful in managing certain cardiac conditions, but it isn’t given as the immediate first-line therapy for chest pain in the ED. It can lower blood pressure and, in patients with airway reactivity, may cause bronchospasm or worsen hemodynamics, so it’s typically not the initial choice before other measures have been started. Tissue plasminogen activator is a thrombolytic used to dissolve clots in certain ST-elevation myocardial infarctions or specific high-risk scenarios, but it requires careful patient selection and ECG-confirmed indications. It’s not administered as a universal first-line med on arrival; its use depends on more definitive diagnosis and timing, with significant bleeding risks to consider. Captopril is an ACE inhibitor used to manage blood pressure and help prevent remodeling after an MI, but it is not started as an immediate first-line treatment in the ED for chest pain. It’s more appropriately introduced after stabilization and assessment of the patient’s hemodynamic status. So the best first-line medication the patient is likely to receive on arrival is nitroglycerin due to its rapid action in reducing myocardial oxygen demand and alleviating angina symptoms.

In acute coronary syndrome, the priority is to relieve chest pain and decrease the heart’s oxygen demand as quickly as possible. Nitroglycerin fits this role because it is a fast-acting vasodilator that lowers preload and, to some extent, afterload. By dilating veins, it reduces the amount of blood returning to the heart, which lessens wall stress and myocardial oxygen consumption, often quickly easing angina symptoms when given sublingually. This makes it a standard first-line intervention in the ED for suspected ACS, often part of the initial MONA approach (Nitrates among the first steps).

Propranolol is a beta-blocker that can be useful in managing certain cardiac conditions, but it isn’t given as the immediate first-line therapy for chest pain in the ED. It can lower blood pressure and, in patients with airway reactivity, may cause bronchospasm or worsen hemodynamics, so it’s typically not the initial choice before other measures have been started.

Tissue plasminogen activator is a thrombolytic used to dissolve clots in certain ST-elevation myocardial infarctions or specific high-risk scenarios, but it requires careful patient selection and ECG-confirmed indications. It’s not administered as a universal first-line med on arrival; its use depends on more definitive diagnosis and timing, with significant bleeding risks to consider.

Captopril is an ACE inhibitor used to manage blood pressure and help prevent remodeling after an MI, but it is not started as an immediate first-line treatment in the ED for chest pain. It’s more appropriately introduced after stabilization and assessment of the patient’s hemodynamic status.

So the best first-line medication the patient is likely to receive on arrival is nitroglycerin due to its rapid action in reducing myocardial oxygen demand and alleviating angina symptoms.